Fluorescent polymerase chain reaction (PCR) kit for detecting CYP2C19 genotypes
A technology of CYP2C19 and genotyping, which is applied in the field of fluorescent PCR kits and genotypes at two sites, which can solve the problems of high requirements for operators and laboratory conditions, many factors affecting the results, expensive reagents and instruments, etc. , to achieve the effects of avoiding reaction product pollution, short reaction time, and intuitive results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] Embodiment 1: the preparation of kit
[0035] 1. Primer design and synthesis
[0036] Use Primer premier5.0 to design upstream and downstream amplification primers for the complete sequence of the CYP2C19 gene. The primers were synthesized by a professional company, and the primers were purified by PAGE.
[0037] The amplified sequence is shown in Table 1:
[0038] Table 1. Specific amplification primer sequences
[0039]
[0040] 2. Preparation of positive control substances for CYP2C19*2 and CYP2C19*3 genes
[0041] In this implementation, there are CYP2C19*2 type positive control substances 1-1, CYP2C19*2 type positive control substances 1-2, CYP2C19*2 type positive control substances 1-3, CYP2C19*3 type positive control substances 2-1, CYP2C19* Type 3 positive control substance 2-2, CYP2C19*3 type positive control substance 2-3.
[0042] CYP2C19*2 type positive control substance 1-1 is inserted with the wild homozygous recombinant plasmid with the nucleotide...
Embodiment 2
[0067] Embodiment 2: the use of kit
[0068] 1. Sample extraction and DNA preparation
[0069] 1) A blood sample is drawn from the patient to be tested to obtain the blood to be tested.
[0070] 2) Obtain DNA from the blood sample, and use a professional company's DNA extraction kit (purchased from Invitrogen) for extraction. Take 2.0 μl of the extract as a PCR reaction template.
[0071] 2. Preparation of positive control substances for CYP2C19*2 and CYP2C19*3 genes
[0072] According to the site to be detected in the sample, take the corresponding CYP2C19*2 positive control substance and CYP2C19*3 positive control substance in this kit.
[0073] 3. Preparation of CYP2C19*2 and CYP2C19*3 gene negative control substances
[0074] Take the β-actin plasmid provided by this kit as a negative control.
[0075] 4. Sample detection
[0076] The nucleic acid extracted in step 1, the positive control substance obtained in step 2, and the negative control substance obtained in st...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com